Rat genetics: the next episode

Trends in Genetics

Volumn 22, Issue 4, 2006, Pages 232-240

  Smits, Bart M G ^a   Cuppen, Edwin ^a  

^a HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CELL NUCLEUS TRANSPLANTATION; DNA POLYMORPHISM; EXPERIMENTAL RAT; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE SILENCING; GENETIC ANALYSIS; GENETICS; GENOME; KNOCKOUT GENE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENICS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; ETHYLNITROSOUREA; GENE SILENCING; GENETIC RESEARCH; GENETIC TECHNIQUES; HUMANS; MUTAGENESIS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; RATS; RECOMBINATION, GENETIC; RNA, SMALL INTERFERING;

EID: 33645840765     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2006.02.009     Document Type: Review

References (92)

1. Gibbs R.A., et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428 (2004) 493-521
2. Jacob H.J., and Kwitek A.E. Rat genetics: attaching physiology and pharmacology to the genome. Nat. Rev. Genet. 3 (2002) 33-42
3. Lindblad-Toh K. Genome sequencing: three's company. Nature 428 (2004) 475-476
4. Hedrich H.J. History, Strains and Models (2000), Academic Press
5. Flint J., et al. Strategies for mapping and cloning quantitative trait genes in rodents. Nat. Rev. Genet. 6 (2005) 271-286
6. Kwitek A.E., et al. High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence. Genome Res. 14 (2004) 750-757
7. Steen R.G., et al. A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res. 9 (1999) AP1-AP8
8. Watanabe T.K., et al. Characterization of newly developed SSLP markers for the rat. Mamm. Genome 11 (2000) 300-305
9. Moreno C., et al. Genome-wide scanning with SSLPs in the rat. Methods Mol. Med. 108 (2004) 131-138
10. Cuppen E. Haplotype-based genetics in mice and rats. Trends Genet. 21 (2005) 318-322
11. Darvasi A. Dissecting complex traits: the geneticists' 'Around the world in 80 days'. Trends Genet. 21 (2005) 373-376
12. Wang J., et al. Computational genetics: from mouse to human?. Trends Genet. 21 (2005) 526-532
13. Olofsson P., et al. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33 (2003) 25-32
14. Cicila G.T., et al. High-resolution mapping of the blood pressure QTL on chromosome 7 using Dahl rat congenic strains. Genomics 72 (2001) 51-60
15. Deschepper C.F., et al. Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses. Circ. Res. 88 (2001) 223-228
16. Pravenec M., et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27 (2001) 156-158
17. Yokoi N., et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31 (2002) 391-394
18. Crackower M.A., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002) 822-828
19. Hubner N., et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37 (2005) 243-253
20. Cowley Jr. A.W., et al. Application of chromosomal substitution techniques in gene-function discovery. J. Physiol. 554 (2004) 46-55
21. Mullins L.J., et al. Transgenesis in the rat. Methods Mol. Biol. 180 (2002) 255-270
22. Lois C., et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295 (2002) 868-872
23. Pfeifer A. Lentiviral transgenesis. Transgenic Res. 13 (2004) 513-522
24. Popova E., et al. Production of transgenic models in hypertension. Methods Mol. Med. 108 (2005) 33-50
25. Shaughnessy L., et al. Novel approaches to models of Alzheimer's disease pathology for drug screening and development. J. Mol. Neurosci. 24 (2004) 23-32
26. von Horsten S., et al. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12 (2003) 617-624
27. Reid W., et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9271-9276
28. Charreau B., et al. Transgenesis in rats: technical aspects and models. Transgenic Res. 5 (1996) 223-234
29. Dorsett Y., and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3 (2004) 318-329
30. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
31. Heasman J. Morpholino oligos: making sense of antisense?. Dev. Biol. 243 (2002) 209-214
32. Scherer L.J., and Rossi J.J. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21 (2003) 1457-1465
33. Thakker D.R., et al. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17270-17275
34. Matsuda T., and Cepko C.L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16-22
35. McCaffrey A.P., et al. RNA interference in adult mice. Nature 418 (2002) 38-39
36. Layzer J.M., et al. In vivo activity of nuclease-resistant siRNAs. RNA 10 (2004) 766-771
37. Hommel J.D., et al. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9 (2003) 1539-1544
38. Van den Haute C., et al. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene Ther. 14 (2003) 1799-1807
39. Xia H., et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10 (2004) 816-820
40. Xia H., et al. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20 (2002) 1006-1010
41. Hemann M.T., et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33 (2003) 396-400
42. Rubinson D.A., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
43. Carmell M.A., et al. Germline transmission of RNAi in mice. Nat. Struct. Biol. 10 (2003) 91-92
44. Hasuwa H., et al. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532 (2002) 227-230
45. Kunath T., et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21 (2003) 559-561
46. Tiscornia G., et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1844-1848
47. Bahi A., et al. Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion. Eur. J. Neurosci. 21 (2005) 3415-3426
48. Lai S.K., et al. Selective knockdown of gene expression of N-methyl-D-aspartate receptor one ameliorates parkinsonian motor symptom in 6-hydroxydopamine-lesioned rats. Neurochem. Int. 45 (2004) 11-22
49. Tan P.H., et al. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 12 (2005) 59-66
50. Dorn G., et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32 (2004) e49
51. Isacson R., et al. Lack of efficacy of 'naked' small interfering RNA applied directly to rat brain. Acta Physiol. Scand. 179 (2003) 173-177
52. Takabatake Y., et al. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther. 12 (2005) 965-973
53. Michel U., et al. Long-term in vivo and in vitro AAV-2-mediated RNA interference in rat retinal ganglion cells and cultured primary neurons. Biochem. Biophys. Res. Commun. 326 (2005) 307-312
54. Zhang Y., et al. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med. 5 (2003) 1039-1045
55. Capecchi M.R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. Genet. 6 (2005) 507-512
56. Jansen G., et al. Reverse genetics by chemical mutagenesis in Caenorhabditis elegans. Nat. Genet. 17 (1997) 119-121
57. Bentley A., et al. Targeted recovery of mutations in Drosophila. Genetics 156 (2000) 1169-1173
58. Winkler S., et al. Target-selected mutant screen by TILLING in Drosophila. Genome Res. 15 (2005) 718-723
59. Wienholds E., et al. Target-selected inactivation of the zebrafish rag1 gene. Science 297 (2002) 99-102
60. McCallum C.M., et al. Targeted screening for induced mutations. Nat. Biotechnol. 18 (2000) 455-457
61. Till B.J., et al. Discovery of induced point mutations in maize genes by TILLING. BMC Plant Biol. 4 (2004) 12
62. Perry J.A., et al. A TILLING reverse genetics tool and a web-accessible collection of mutants of the legume Lotus japonicus. Plant Physiol. 131 (2003) 866-871
63. Smits B.M., et al. Target-selected mutagenesis of the rat. Genomics 83 (2004) 332-334
64. Zan Y., et al. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat. Biotechnol. 21 (2003) 645-651
65. Smits, B.M. et al. Routine generation of gene knockouts and mutant models in the laboratory rat. Pharmacogenetics and genomics (in press)
66. Coghill E.L., et al. A gene-driven approach to the identification of ENU mutants in the mouse. Nat. Genet. 30 (2002) 255-256
67. Quwailid M.M., et al. A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm. Genome 15 (2004) 585-591
68. Till B.J., et al. Large-scale discovery of induced point mutations with high-throughput TILLING. Genome Res. 13 (2003) 524-530
69. Wienholds E., et al. Efficient target-selected mutagenesis in zebrafish. Genome Res. 13 (2003) 2700-2707
70. Beier D.R. Sequence-based analysis of mutagenized mice. Mamm. Genome 11 (2000) 594-597
71. Concepcion D., et al. Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. Genetics 168 (2004) 953-959
72. Syvanen, A.C. (2005) Toward genome-wide SNP genotyping. Nat. Genet. 37 (Suppl.) S5-10
73. Margulies M., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437 (2005) 376-380
74. Shendure J., et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309 (2005) 1728-1732
75. Hrabe de Angelis M.H., et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25 (2000) 444-447
76. Nolan P.M., et al. Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm. Genome 11 (2000) 500-506
77. Smits B.M., et al. Identification of a rat model for Usher Syndrome Type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics. Genetics 170 (2005) 1887-1896
78. Buehr M., et al. Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol. Reprod. 68 (2003) 222-229
79. Zhou Q., et al. Generation of fertile cloned rats by regulating oocyte activation. Science 302 (2003) 1179
80. Dai Y., et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20 (2002) 251-255
81. Lai L., et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295 (2002) 1089-1092
82. Mullins L.J., et al. Nuclear transfer in rodents. J. Physiol. 554 (2004) 4-12
83. Ryu B.Y., et al. Conservation of spermatogonial stem cell self-renewal signaling between mouse and rat. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14302-14307
84. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2 (2001) 743-755
85. Kile B.T., and Hilton D.J. The art and design of genetic screens: mouse. Nat. Rev. Genet. 6 (2005) 557-567
86. Hamra F.K., et al. Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14931-14936
87. Dittgen T., et al. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18206-18211
88. Bolon B. The Laboratory Rat (2000), Academic Press
89. Fire A., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
90. Schinke M., et al. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3975-3980
91. Caplen N.J., et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9742-9747
92. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498